ACell’s New MatriStem® Multilayer Wound Matrix Addresses Hard-to-Heal, Full Thickness Wounds

Heard of ACell, Inc.? Neither had we, but now the regenerative medicine company has announced the launch of its new MatriStem® Multilayer Wound Matrix device for deep, hard-to-heal, full-thickness wounds.

Background

ACell, Inc. offers what it calls the next generation of regenerative medicine through the development and commercialization of unique extracellular matrix(ECM) products to repair and remodel damaged tissues in a broad range of applications. Its patented MatriStem ECM medical devices maintain and support a healing environment through constructive remodeling and are available in particle and sheet forms for the treatment of acute wounds and various surgical procedures.

MatriStem devices have received multiple 510(k) clearances from the FDA and are indicated for wound management including for pressure ulcers, venous ulcers, diabetic ulcers, surgical wounds and trauma wounds, and the reinforcement of soft tissue where weakness exists in urological, gynecological and gastroenterological anatomy. The products are described as  medical devices that maintain and support a healing environment through constructive remodeling. Comprised of naturally-occurring urinary bladder matrix (UBM), MatriStem maintains an intact epithelial basement membrane which is hypothesized to facilitate the body’s natural healing potential.

Of its MatriStem Multilayer Wound Matrix, Acell says the one-to-one (1:1) mesh design is built to accommodate moderate to heavy wound exudate and provides effective contouring functionality in wound application.

The device is said to be easy to prepare, apply and fixate and requires no special handling or storage requirements. MatriStem Multilayer Wound Matrix is appropriate for both acute and chronic wounds.

Company comments

Jim DeFrancesco, Chief Executive Officer and Board Director, remarked, “ACell has developed MatriStem Multilayer Wound Matrix to address an unmet need in the area of acute and chronic wound care management. The launch of this new product provides a new option for physicians treating patients suffering from deep, hard-to-heal wounds.”

Source: ACell, Inc., PR Newswire

Share your thoughts

Your email address will not be published. Required fields are marked *